How many studies have been conducted on Paliperidone Palmitate?

BiohacksAI has indexed 299 PubMed studies on Paliperidone Palmitate, including 49 randomized controlled trials (RCTs). 80% of studies involve human subjects.

What are the main research areas for Paliperidone Palmitate?

The primary research domains for Paliperidone Palmitate are 🫁 Liver & Detox, 🧠 Focus & Attention, 😴 Sleep. This is based on analysis of 299 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Paliperidone Palmitate

A benzisoxazole derivative and active metabolite of RISPERIDONE that functions as a DOPAMINE D2 RECEPTOR ANTAGONIST and SEROTONIN 5-HT2 RECEPTOR ANTAGONIST. It is an ANTIPSYCHOTIC AGENT used in the treatment of SCHIZOPHRENIA.

299+ PubMed studies analyzed · 49 RCTs · Evidence Score: 57.2

Research Domains

Paliperidone Palmitate has been studied across 7 research domains including 🫁 Liver & Detox, 🧠 Focus & Attention, 😴 Sleep, 💊 Pain, 🔥 Metabolic. The primary research focus is 🫁 Liver & Detox with 3% of studies addressing this area.

Loading evidence profile...

This evidence profile for Paliperidone Palmitate is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.